Annual CFO
-$31.10 M
+$3.78 M+10.84%
December 1, 2024
Summary
- As of February 26, 2025, GLYC annual cash flow from operations is -$31.10 million, with the most recent change of +$3.78 million (+10.84%) on December 1, 2024.
- During the last 3 years, GLYC annual CFO has risen by +$26.39 million (+45.91%).
- GLYC annual CFO is now -324.48% below its all-time high of $13.85 million, reached on December 31, 2011.
Performance
GLYC Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.70 M
+$4.29 M+53.70%
December 1, 2024
Summary
- As of February 26, 2025, GLYC quarterly cash flow from operations is -$3.70 million, with the most recent change of +$4.29 million (+53.70%) on December 1, 2024.
- Over the past year, GLYC quarterly CFO has increased by +$4.29 million (+53.70%).
- GLYC quarterly CFO is now -127.29% below its all-time high of $13.56 million, reached on September 30, 2015.
Performance
GLYC Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$31.10 M
+$3.91 M+11.18%
December 1, 2024
Summary
- As of February 26, 2025, GLYC TTM cash flow from operations is -$31.10 million, with the most recent change of +$3.91 million (+11.18%) on December 1, 2024.
- Over the past year, GLYC TTM CFO has increased by +$3.91 million (+11.18%).
- GLYC TTM CFO is now -1235.60% below its all-time high of -$2.33 million, reached on June 30, 2014.
Performance
GLYC TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
GLYC Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10.8% | +53.7% | +11.2% |
| 3 y3 years | +45.9% | +53.7% | +11.2% |
| 5 y5 years | +40.2% | +53.7% | +11.2% |
GLYC Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +45.9% | at high | +77.2% | at high | +47.9% |
| 5 y | 5-year | at high | +45.9% | -5.8% | +78.2% | at high | +47.9% |
| alltime | all time | -324.5% | +45.9% | -127.3% | +78.2% | -1235.6% | +47.9% |
GlycoMimetics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$31.10 M(-10.8%) | -$3.70 M(-53.7%) | -$31.10 M(-11.2%) |
| Sep 2024 | - | -$7.99 M(-10.1%) | -$35.01 M(-1.9%) |
| Jun 2024 | - | -$8.89 M(-15.4%) | -$35.70 M(+5.7%) |
| Mar 2024 | - | -$10.51 M(+38.0%) | -$33.78 M(-3.1%) |
| Dec 2023 | -$34.88 M(-24.9%) | -$7.62 M(-12.3%) | -$34.88 M(-0.8%) |
| Sep 2023 | - | -$8.68 M(+24.5%) | -$35.18 M(+0.2%) |
| Jun 2023 | - | -$6.97 M(-39.9%) | -$35.11 M(-20.9%) |
| Mar 2023 | - | -$11.61 M(+46.7%) | -$44.37 M(-4.5%) |
| Dec 2022 | -$46.46 M(-19.2%) | -$7.91 M(-8.2%) | -$46.46 M(-9.5%) |
| Sep 2022 | - | -$8.62 M(-46.9%) | -$51.35 M(-14.0%) |
| Jun 2022 | - | -$16.23 M(+18.5%) | -$59.68 M(+4.6%) |
| Mar 2022 | - | -$13.70 M(+7.0%) | -$57.06 M(-0.7%) |
| Dec 2021 | -$57.49 M(+46.5%) | -$12.81 M(-24.4%) | -$57.49 M(+5.7%) |
| Sep 2021 | - | -$16.95 M(+24.5%) | -$54.37 M(+11.1%) |
| Jun 2021 | - | -$13.61 M(-3.6%) | -$48.93 M(-1.9%) |
| Mar 2021 | - | -$14.13 M(+45.8%) | -$49.87 M(+27.1%) |
| Dec 2020 | -$39.24 M(-24.5%) | -$9.69 M(-15.8%) | -$39.24 M(-7.3%) |
| Sep 2020 | - | -$11.50 M(-20.9%) | -$42.35 M(-4.4%) |
| Jun 2020 | - | -$14.55 M(+315.8%) | -$44.29 M(+7.7%) |
| Mar 2020 | - | -$3.50 M(-72.6%) | -$41.14 M(-20.9%) |
| Dec 2019 | -$51.98 M(+20.0%) | -$12.79 M(-4.9%) | -$51.98 M(+5.7%) |
| Sep 2019 | - | -$13.45 M(+18.0%) | -$49.17 M(+7.3%) |
| Jun 2019 | - | -$11.39 M(-20.6%) | -$45.81 M(-3.5%) |
| Mar 2019 | - | -$14.35 M(+43.8%) | -$47.47 M(+9.6%) |
| Dec 2018 | -$43.33 M | -$9.98 M(-1.0%) | -$43.33 M(+3.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$10.08 M(-22.8%) | -$41.72 M(+10.2%) |
| Jun 2018 | - | -$13.06 M(+27.9%) | -$37.87 M(+22.5%) |
| Mar 2018 | - | -$10.21 M(+22.0%) | -$30.92 M(+3.9%) |
| Dec 2017 | -$29.77 M(+0.1%) | -$8.37 M(+34.3%) | -$29.77 M(+8.8%) |
| Sep 2017 | - | -$6.23 M(+2.0%) | -$27.35 M(-4.3%) |
| Jun 2017 | - | -$6.11 M(-32.6%) | -$28.60 M(-3.3%) |
| Mar 2017 | - | -$9.06 M(+52.2%) | -$29.56 M(-0.6%) |
| Dec 2016 | -$29.73 M(+260.7%) | -$5.95 M(-20.3%) | -$29.73 M(-3.3%) |
| Sep 2016 | - | -$7.47 M(+5.6%) | -$30.73 M(+216.9%) |
| Jun 2016 | - | -$7.08 M(-23.3%) | -$9.70 M(+10.6%) |
| Mar 2016 | - | -$9.23 M(+32.7%) | -$8.77 M(+6.4%) |
| Dec 2015 | -$8.24 M(+92.5%) | -$6.96 M(-151.3%) | -$8.24 M(+10.8%) |
| Sep 2015 | - | $13.56 M(-320.8%) | -$7.44 M(-71.1%) |
| Jun 2015 | - | -$6.14 M(-29.4%) | -$25.76 M(+147.7%) |
| Mar 2015 | - | -$8.71 M(+41.4%) | -$10.40 M(+142.9%) |
| Dec 2014 | -$4.28 M(-72.4%) | -$6.15 M(+29.5%) | -$4.28 M(+15.9%) |
| Sep 2014 | - | -$4.75 M(-151.6%) | -$3.69 M(+58.6%) |
| Jun 2014 | - | $9.21 M(-456.1%) | -$2.33 M(-83.7%) |
| Mar 2014 | - | -$2.59 M(-53.5%) | -$14.25 M(-8.3%) |
| Dec 2013 | -$15.54 M(+48.4%) | -$5.57 M(+64.2%) | -$15.54 M(+55.8%) |
| Sep 2013 | - | -$3.39 M(+25.2%) | -$9.97 M(+51.5%) |
| Jun 2013 | - | -$2.71 M(-30.2%) | -$6.58 M(+69.8%) |
| Mar 2013 | - | -$3.88 M | -$3.88 M |
| Dec 2012 | -$10.47 M(-175.6%) | - | - |
| Dec 2011 | $13.85 M | - | - |
FAQ
- What is GlycoMimetics annual cash flow from operations?
- What is the all time high annual CFO for GlycoMimetics?
- What is GlycoMimetics annual CFO year-on-year change?
- What is GlycoMimetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for GlycoMimetics?
- What is GlycoMimetics quarterly CFO year-on-year change?
- What is GlycoMimetics TTM cash flow from operations?
- What is the all time high TTM CFO for GlycoMimetics?
- What is GlycoMimetics TTM CFO year-on-year change?
What is GlycoMimetics annual cash flow from operations?
The current annual CFO of GLYC is -$31.10 M
What is the all time high annual CFO for GlycoMimetics?
GlycoMimetics all-time high annual cash flow from operations is $13.85 M
What is GlycoMimetics annual CFO year-on-year change?
Over the past year, GLYC annual cash flow from operations has changed by +$3.78 M (+10.84%)
What is GlycoMimetics quarterly cash flow from operations?
The current quarterly CFO of GLYC is -$3.70 M
What is the all time high quarterly CFO for GlycoMimetics?
GlycoMimetics all-time high quarterly cash flow from operations is $13.56 M
What is GlycoMimetics quarterly CFO year-on-year change?
Over the past year, GLYC quarterly cash flow from operations has changed by +$4.29 M (+53.70%)
What is GlycoMimetics TTM cash flow from operations?
The current TTM CFO of GLYC is -$31.10 M
What is the all time high TTM CFO for GlycoMimetics?
GlycoMimetics all-time high TTM cash flow from operations is -$2.33 M
What is GlycoMimetics TTM CFO year-on-year change?
Over the past year, GLYC TTM cash flow from operations has changed by +$3.91 M (+11.18%)